Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +766,19% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +766,19% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/07/14 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01/01/99 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/08/21 |
Investor Relations Contact | 45 | 13/11 | |
Tom Garner
PRN | Corporate Officer/Principal | - | 09/10/23 |
Wendy Mcdermott
HRO | Human Resources Officer | - | 01/01/22 |
Comptroller/Controller/Auditor | 56 | 01/06/17 | |
General Counsel | - | 04/11/14 | |
Brian Crum
LAW | General Counsel | 51 | 01/01/01 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01/02/01 |
Ray Debbane
CHM | Chairman | 69 | 01/08/07 |
Director/Board Member | 65 | 28/08/07 | |
Philippe Amouyal
BRD | Director/Board Member | 65 | 01/08/07 |
Judith Swain
BRD | Director/Board Member | 75 | 01/09/07 |
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/07/14 |
Samuel Barker
BRD | Director/Board Member | 81 | 01/03/00 |
Diane Sullivan
BRD | Director/Board Member | 62 | 28/07/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 362 972 111 | 357 294 841 ( 98,44 %) | 1 528 008 ( 0,4210 %) | 98,44 % |
Azione B | 0 | 2 304 147 | 0 | 0 |
Coordinate società
Lexicon Pharmaceuticals, Inc.
2445 Technology Forest Boulevard 11th floor
77381-1160, The Woodlands
+
http://www.lexpharma.com![Indirizzo Lexicon Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/9868.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+15,58% | 121 Mrd | |
+16,60% | 110 Mrd | |
+18,81% | 25,93 Mrd | |
-24,33% | 19,27 Mrd | |
-19,49% | 16,01 Mrd | |
-17,95% | 15,66 Mrd | |
-46,81% | 14,89 Mrd | |
+58,78% | 14,47 Mrd | |
+4,91% | 13,91 Mrd |